2019 Genitourinary Cancers Symposium
Read More24 / 64
Abstract 228, "Results of a 50 patient single-centre phase II prospective trial of Lutetium-177 PSMA-617 theranostics in metastatic castrate-resistant prostate cancer," presented by Dr. Michael Hofman, right, and John Viloet, left, during Poster Session A
San Francisco, CA - 2019 Genitourinary Cancers Symposium – Abstract 228, "Results of a 50 patient single-centre phase II prospective trial of Lutetium-177 PSMA-617 theranostics in metastatic castrate-resistant prostate cancer," presented by Dr. Michael Hofman, right, and John Viloet, left, during Poster Session A Photo by © ASCO/Todd Buchanan 2019
2318 Mill Road, Suite 800, Alexandria, VA 22314 | Phone: (571) 483-1300
© 2005-2017 American Society of Clinical Oncology (ASCO). All rights reserved worldwide.
© 2005-2017 American Society of Clinical Oncology (ASCO). All rights reserved worldwide.